| Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients P Cacoub, C Renou, E Rosenthal, P Cohen, I Loury, V Loustaud-Ratti, ... Medicine 79 (1), 47-56, 2000 | 809 | 2000 |
| Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study F Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ... The Lancet 393 (10179), 1453-1464, 2019 | 563 | 2019 |
| Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890 C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ... Journal of hepatology 59 (3), 434-441, 2013 | 556 | 2013 |
| Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a … M Bourlière, JP Bronowicki, V De Ledinghen, C Hézode, F Zoulim, ... The Lancet Infectious Diseases 15 (4), 397-404, 2015 | 373 | 2015 |
| Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis C Hézode, H Fontaine, C Dorival, F Zoulim, D Larrey, V Canva, ... Gastroenterology 147 (1), 132-142. e4, 2014 | 334 | 2014 |
| Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases M Ramos-Casals, V Loustaud-Ratti, S De Vita, M Zeher, JA Bosch, ... Medicine 84 (2), 81-89, 2005 | 267 | 2005 |
| Efficacy of an interferon-and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection GT Everson, KD Sims, M Rodriguez-Torres, C Hézode, E Lawitz, ... Gastroenterology 146 (2), 420-429, 2014 | 233 | 2014 |
| Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients A Sparsa, E Liozon, F Herrmann, K Ly, V Lebrun, P Soria, ... Archives of dermatology 138 (7), 885-890, 2002 | 221 | 2002 |
| Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study C Payan, F Roudot‐Thoraval, P Marcellin, N Bled, G Duverlie, ... Journal of viral hepatitis 12 (4), 405-413, 2005 | 185 | 2005 |
| Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection L Arcaini, C Besson, M Frigeni, H Fontaine, M Goldaniga, M Casato, ... Blood, The Journal of the American Society of Hematology 128 (21), 2527-2532, 2016 | 184 | 2016 |
| Short‐term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus–related polyarteritis nodosa L Guillevin, A Mahr, P Cohen, C Larroche, V Queyrel, V Loustaud‐Ratti, ... Arthritis care & research 51 (3), 482-487, 2004 | 161 | 2004 |
| Long‐term outcomes among participants in the WEGENT trial of remission‐maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis X Puéchal, C Pagnoux, É Perrodeau, M Hamidou, JJ Boffa, X Kyndt, ... Arthritis & rheumatology 68 (3), 690-701, 2016 | 149 | 2016 |
| Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection A Abergel, S Metivier, D Samuel, D Jiang, K Kersey, PS Pang, ... Hepatology 64 (4), 1049-1056, 2016 | 148 | 2016 |
| Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients S Pol, M Bourliere, S Lucier, C Hezode, C Dorival, D Larrey, ... Journal of hepatology 66 (1), 39-47, 2017 | 147 | 2017 |
| Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function J Jacques, L Pagnon, F Hure, R Legros, S Crepin, AL Fauchais, S Palat, ... Endoscopy 51 (01), 40-49, 2019 | 141 | 2019 |
| Personalized adapted physical activity before liver transplantation: acceptability and results M Debette-Gratien, T Tabouret, MT Antonini, F Dalmay, P Carrier, ... Transplantation 99 (1), 145-150, 2015 | 141 | 2015 |
| Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study A Abergel, T Asselah, S Metivier, K Kersey, D Jiang, H Mo, PS Pang, ... The Lancet infectious diseases 16 (4), 459-464, 2016 | 135 | 2016 |
| Articular manifestations in primary Sjögren’s syndrome: clinical significance and prognosis of 188 patients AL Fauchais, B Ouattara, G Gondran, F Lalloue, D Petit, K Ly, M Lambert, ... Rheumatology 49 (6), 1164-1172, 2010 | 134 | 2010 |
| Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta D Roulot, S Brichler, R Layese, Z BenAbdesselam, F Zoulim, V Thibault, ... Journal of Hepatology 73 (5), 1046-1062, 2020 | 127 | 2020 |
| Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. V Loustaud-Ratti, A Riche, E Liozon, F Labrousse, P Soria, S Rogez, ... The Journal of rheumatology 28 (10), 2245-2251, 2001 | 113 | 2001 |
